Efficacy and Safety of High-Flow Nasal Cannula Oxygen Therapy in Moderate and Severe Bronchiolitis

Journal Title: Journal of Clinical and Diagnostic Research - Year 2019, Vol 13, Issue 3

Abstract

ABSTRACT Introduction: Heated humidified High-Flow Nasal Cannula therapy (HFNC) is a non-invasive form of oxygen delivery, in which oxygen supports respiration by reducing nasopharyngeal dead space, decreasing airway oedema, enhancing ciliary activity and providing positive airway pressure. Aim: To evaluate efficacy and safety of HFNC oxygen therapy in children with moderate and severe bronchiolitis. Materials and Methods: The present prospective study was carried out in PICU of a tertiary care hospital over a period of 24 months. Twenty two children between the ages of 2 months to 2 years who were previously healthy and diagnosed with moderate and severe bronchiolitis were included. A standard protocol was used for all the children with regards to the initiation, monitoring and weaning from HFNC. Outcome parameters measured were Heart Rate (HR), Respiratory Rate (RR), oxygen saturation (SpO2), Arterial Blood Gases (ABG), hours of therapy, and failure of HFNC oxygen therapy. Parameters were compared using two tailed test. Results: Out of 22 children, 15 were male and 7 were female with M:F ratio 2:1. Eight children had moderate bronchiolitis and 14 children had severe bronchiolitis. The mean age (±SD) was 7.18±4.48 months. The mean baseline HR, RR, SpO2, PaCO2, PaO2 levels were 158.50±35.19 beats/min, 68.64±10.72/min, 88.68±2.12%, 31.23±6.12 mmHg, 122.73±44.94 mmHg respectively. At the end of one hour of HFNC oxygen therapy, mean HR was 151.59±14.61 beats/min, RR 59.32±9.61/min, SpO2 99.59±0.59%, PaCO2 30.99±6.16 mmHg and PaO2 125.71±37.12 mmHg. There was statistically significant improvement (p<0.05) in the work of breathing as indicated by fall in mean HR and RR along with increase in mean SpO2 level after one hour of HFNC oxygen therapy. This improvement was consistently seen till the end of the study. The mean hours for which HFNC oxygen therapy was required was 43.27±16.31 hours. One child failed HFNC oxygen therapy and required invasive ventilation. There were no serious adverse events. Conclusion: HFNC oxygen therapy significantly decreases the work of breathing and improves oxygen saturation in moderate and severe bronchiolitis.

Authors and Affiliations

Sunil V Kapur, Jitendra S Oswal, Bhakti Sarangi

Keywords

Related Articles

Evaluation of Cellular Response to the Indigenously Fabricated Dental Magnet for Application in Prosthodontics- An Animal Study

Introduction: Prosthetic constructions retained by magnets play an important role in the application of dental removable prosthesis and orofacial epithesis. One of the issues during the introduction of these magnets into...

Upper Gastrointestinal Bleed as a Manifestation of Poorly Differentiated Metastatic Squamous Cell Carcinoma of the Lung

Gastrointestinal (GI) metastasis from primary lung cancer is a rare clinical finding. Lung cancer most often metastasizes to the brain, bone, liver, and adrenal glands; with gastrointestinal involvement being very rare....

Cymbopogon Citratus (Lemongrass Oil) Oral Sprays as Inhibitors of Mutans Streptococci Biofilm Formation

ABSTRACT Introduction: Dental caries that occurs in young children or Early Childhood Caries (ECC) remains highly prevalent worldwide. Streptococcus mutans is not only one of the pioneer groups in plaque formation but is...

Lymph Node Myeloid Sarcoma as a First Presentation of CML Blast Crisis: A Rare Case Report with Review of Literature

ABSTRACT Myeloid Sarcoma (MS) is an extra-medullary accumulation of the immature cells of granulocytic cell lineage. It has been reported commonly in the setting of acute myelogenous leukaemia, however its occurrence in...

Download PDF file
  • EP ID EP581535
  • DOI 10.7860/JCDR/2019/38340.12703
  • Views 99
  • Downloads 0

How To Cite

Sunil V Kapur, Jitendra S Oswal, Bhakti Sarangi (2019). Efficacy and Safety of High-Flow Nasal Cannula Oxygen Therapy in Moderate and Severe Bronchiolitis. Journal of Clinical and Diagnostic Research, 13(3), 11-14. https://europub.co.uk/articles/-A-581535